Jean-Marc Le Doussal

Founder at Remora Capital SA

61 year

Health Technology

Finance

Profile

Jean-Marc Le Doussal is the founder.
He founded Remora Capital SA in 2009 and currently holds the title of Managing Partner.
He is also currently the President of OGD2 Pharma SAS.
In the past, he served as the Chairman of Telix Pharmaceuticals SAS.

Jean-Marc Le Doussal active positions

Companies	Position	Start
Remora Capital SA Remora Capital SA Investment ManagersFinance Remora Capital SA (Remora Capital) is a venture capital firm founded by Dr. Jean-Marc Le Doussal in 2009. The firm is headquartered in Switzerland.	Founder	22/09/2009
OGD2 Pharma SAS OGD2 Pharma SAS BiotechnologyHealth Technology OGD2 Pharma SAS develops and commercializes anti-GD2 cancer immunotherapies that target O-acetylated-GD2. The firm continues exploring the potential of therapies targeting the OAcGD2 antigen in various cancers. The company is headquartered in Nantes, France.	President	-

All active positions of Jean-Marc Le Doussal

Former positions of Jean-Marc Le Doussal

Companies	Position	End
Telix Pharmaceuticals SAS Telix Pharmaceuticals SAS BiotechnologyHealth Technology Telix Pharmaceuticals SAS engages in the pharmaceutical industry. It provides research in biotechnology. The company was founded on July 25, 2008 and is headquartered in Nantes, France.	Chairman	-

See the detail of Jean-Marc Le Doussal's experience

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Jean-Marc Le Doussal's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	3
Remora Capital SA Remora Capital SA Investment ManagersFinance Remora Capital SA (Remora Capital) is a venture capital firm founded by Dr. Jean-Marc Le Doussal in 2009. The firm is headquartered in Switzerland.	Finance
Telix Pharmaceuticals SAS Telix Pharmaceuticals SAS BiotechnologyHealth Technology Telix Pharmaceuticals SAS engages in the pharmaceutical industry. It provides research in biotechnology. The company was founded on July 25, 2008 and is headquartered in Nantes, France.	Health Technology
OGD2 Pharma SAS OGD2 Pharma SAS BiotechnologyHealth Technology OGD2 Pharma SAS develops and commercializes anti-GD2 cancer immunotherapies that target O-acetylated-GD2. The firm continues exploring the potential of therapies targeting the OAcGD2 antigen in various cancers. The company is headquartered in Nantes, France.	Health Technology

See company connections